June 25, 2013

Purchasing Decisions in an Accountable-Care World: How Will Provider Groups Define Value?

Co-Sponsored by The National Pharmaceutical Council

As hospitals and health systems face declining reimbursement, some are focusing on managing supply costs that account for 30 to 50 percent of their operating expenses more effectively. This creates new scrutiny of the value of medical device, equipment and biopharmaceutical products. Large systems are adopting sophisticated supply chain management operations that engage their physicians in evaluating medical products. Systems like Ascension Health, Kaiser Permanente, Partners Healthcare and Carolinas Health System detailed their approaches, which they believe have saved hundreds of millions in annual costs. As use of such strategies grows, pharmaceutical and device firms are crafting new partnerships that focus on helping health systems meet specific performance goals. These efforts will have both positive and negative impacts on future product innovation.

Agenda

Participants